These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19477026)

  • 1. A cutoff point for peak oxygen consumption in the prognosis of heart failure patients with β-blocker therapy.
    Guimaraes GV; d'Avila VM; Silva MS; Ferreira SA; Ciolac EG; Carvalho VO; Bocchi EA
    Int J Cardiol; 2010 Nov; 145(1):75-7. PubMed ID: 19477026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of ventilatory efficiency with beta-blocker therapy in heart failure.
    Arena RA; Guazzi M; Myers J; Abella J
    Med Sci Sports Exerc; 2007 Feb; 39(2):213-9. PubMed ID: 17277583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of age on aerobic capacity in heart failure patients under beta-blocker therapy: possible impact in clinical decision-making?
    Ciolac EG; Bocchi EA; Fernandes da Silva MM; Tavares AC; Teixeira-Neto IS; Guimarães GV
    Cardiol J; 2013; 20(6):655-61. PubMed ID: 24338544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peak exercise oxygen pulse and prognosis in chronic heart failure.
    Lavie CJ; Milani RV; Mehra MR
    Am J Cardiol; 2004 Mar; 93(5):588-93. PubMed ID: 14996584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure.
    Cohen-Solal A; Tabet JY; Logeart D; Bourgoin P; Tokmakova M; Dahan M
    Eur Heart J; 2002 May; 23(10):806-14. PubMed ID: 12009721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure.
    Florea VG; Henein MY; Anker SD; Francis DP; Chambers JS; Ponikowski P; Coats AJ
    Eur Heart J; 2000 Jan; 21(2):146-53. PubMed ID: 10637088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greater prognostic value of peak VO2 after exercise training program completion in heart failure patients.
    Tabet JY; Meurin P; Benzidi Y; Beauvais F; Ben Driss A; Weber H; Renaud N; Dumaine R; Grosdemouge A; Cohen Solal A
    Int J Cardiol; 2013 Oct; 168(4):4139-44. PubMed ID: 23911267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of peak exercise oxygen consumption and the heart failure survival score to predict survival in patients >65 years of age with heart failure.
    Parikh MN; Lund LH; Goda A; Mancini D
    Am J Cardiol; 2009 Apr; 103(7):998-1002. PubMed ID: 19327430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of β-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure.
    Hirsh BJ; Mignatti A; Garan AR; Uriel N; Colombo P; Sims DB; Jorde UP
    Circ Heart Fail; 2012 Sep; 5(5):560-5. PubMed ID: 22855557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of cardiac index and peak exercise oxygen consumption for determining priority for cardiac transplantation.
    Methvin A; Georgiopoulou VV; Kalogeropoulos AP; Malik A; Anarado P; Chowdhury M; Hussain I; Book WM; Laskar SR; Vega JD; Smith AL; Butler J
    Am J Cardiol; 2010 May; 105(9):1353-5. PubMed ID: 20403492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case for assessment of oscillatory breathing during cardiopulmonary exercise test in risk stratification of elderly patients with chronic heart failure.
    Scardovi AB; De Maria R; Ferraironi A; Gatto L; Celestini A; Forte S; Parolini M; Sciarretta S; Ricci R; Guazzi M
    Int J Cardiol; 2012 Feb; 155(1):115-9. PubMed ID: 21402422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cardiopulmonary exercise variables in chronic heart failure patients with or without beta-blocker therapy.
    Tabet JY; Metra M; Thabut G; Logeart D; Cohen-Solal A
    Am J Cardiol; 2006 Aug; 98(4):500-3. PubMed ID: 16893705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
    Pascual-Figal DA; Peñafiel P; Nicolas F; de la Morena G; Ansaldo P; Redondo B; Sánchez Mas J; Valdés M
    Rev Esp Cardiol; 2008 Mar; 61(3):260-8. PubMed ID: 18361899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2).
    Francis DP; Shamim W; Davies LC; Piepoli MF; Ponikowski P; Anker SD; Coats AJ
    Eur Heart J; 2000 Jan; 21(2):154-61. PubMed ID: 10637089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice?
    Opasich C; Pinna GD; Mazza A; Febo O; Riccardi R; Riccardi PG; Capomolla S; Forni G; Cobelli F; Tavazzi L
    Eur Heart J; 2001 Mar; 22(6):488-96. PubMed ID: 11237544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of non-invasive measurement of cardiac output during sub-maximal exercise to predict outcome in patients with chronic heart failure.
    Goda A; Lang CC; Williams P; Jones M; Farr MJ; Mancini DM
    Am J Cardiol; 2009 Dec; 104(11):1556-60. PubMed ID: 19932792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited predictive value of cardiopulmonary exercise indices in patients with moderate chronic heart failure treated with carvedilol.
    Corrà U; Mezzani A; Bosimini E; Scapellato F; Temporelli PL; Eleuteri E; Giannuzzi P
    Am Heart J; 2004 Mar; 147(3):553-60. PubMed ID: 14999209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of heart rate recovery in patients with heart failure.
    Arena R; Guazzi M; Myers J; Peberdy MA
    Am Heart J; 2006 Apr; 151(4):851.e7-13. PubMed ID: 16569547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure.
    de Groote P; Dagorn J; Soudan B; Lamblin N; McFadden E; Bauters C
    J Am Coll Cardiol; 2004 May; 43(9):1584-9. PubMed ID: 15120815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.